Literature DB >> 28372529

Panel 4: Report of the Microbiology Panel.

Stephen J Barenkamp1, Tasnee Chonmaitree2, Anders P Hakansson3, Terho Heikkinen4, Samantha King5, Johanna Nokso-Koivisto6, Laura A Novotny5, Janak A Patel2, Melinda Pettigrew7, W Edward Swords8.   

Abstract

Objective To perform a comprehensive review of the literature from July 2011 until June 2015 on the virology and bacteriology of otitis media in children. Data Sources PubMed database of the National Library of Medicine. Review Methods Two subpanels comprising experts in the virology and bacteriology of otitis media were created. Each panel reviewed the relevant literature in the fields of virology and bacteriology and generated draft reviews. These initial reviews were distributed to all panel members prior to meeting together at the Post-symposium Research Conference of the 18th International Symposium on Recent Advances in Otitis Media, National Harbor, Maryland, in June 2015. A final draft was created, circulated, and approved by all panel members. Conclusions Excellent progress has been made in the past 4 years in advancing our understanding of the microbiology of otitis media. Numerous advances were made in basic laboratory studies, in animal models of otitis media, in better understanding the epidemiology of disease, and in clinical practice. Implications for Practice (1) Many viruses cause acute otitis media without bacterial coinfection, and such cases do not require antibiotic treatment. (2) When respiratory syncytial virus, metapneumovirus, and influenza virus peak in the community, practitioners can expect to see an increase in clinical otitis media cases. (3) Biomarkers that predict which children with upper respiratory tract infections will develop otitis media may be available in the future. (4) Compounds that target newly identified bacterial virulence determinants may be available as future treatment options for children with otitis media.

Entities:  

Keywords:  bacteriology; microbiology; otitis media; virology

Mesh:

Year:  2017        PMID: 28372529      PMCID: PMC5490388          DOI: 10.1177/0194599816639028

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  138 in total

1.  Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen.

Authors:  Stefan P W de Vries; Sacha A F T van Hijum; Wolfgang Schueler; Kristian Riesbeck; John P Hays; Peter W M Hermans; Hester J Bootsma
Journal:  J Bacteriol       Date:  2010-05-07       Impact factor: 3.490

2.  Mobile genetic elements in Moraxella catarrhalis.

Authors:  John Hays
Journal:  Mob Genet Elements       Date:  2011-07-01

3.  Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.

Authors:  Katie J Edwards; Simon Allen; Bradford W Gibson; Anthony A Campagnari
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

4.  Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.

Authors:  L E Cron; K Stol; P Burghout; S van Selm; E R Simonetti; H J Bootsma; P W M Hermans
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

5.  Nontypeable Streptococcus pneumoniae as an otopathogen.

Authors:  Qingfu Xu; Ravinder Kaur; Janet R Casey; Vishakha Sabharwal; Stephen Pelton; Michael E Pichichero
Journal:  Diagn Microbiol Infect Dis       Date:  2011-02       Impact factor: 2.803

6.  Moraxella catarrhalis expresses a cardiolipin synthase that impacts adherence to human epithelial cells.

Authors:  Sean W Buskirk; Eric R Lafontaine
Journal:  J Bacteriol       Date:  2013-10-18       Impact factor: 3.490

7.  Physiologic cold shock of Moraxella catarrhalis affects the expression of genes involved in the iron acquisition, serum resistance and immune evasion.

Authors:  Violeta Spaniol; Rolf Troller; André Schaller; Christoph Aebi
Journal:  BMC Microbiol       Date:  2011-08-12       Impact factor: 3.605

8.  Control of virulence by small RNAs in Streptococcus pneumoniae.

Authors:  Beth Mann; Tim van Opijnen; Jianmin Wang; Caroline Obert; Yong-Dong Wang; Robert Carter; Daniel J McGoldrick; Granger Ridout; Andrew Camilli; Elaine I Tuomanen; Jason W Rosch
Journal:  PLoS Pathog       Date:  2012-07-12       Impact factor: 6.823

9.  CYLD negatively regulates nontypeable Haemophilus influenzae-induced IL-8 expression via phosphatase MKP-1-dependent inhibition of ERK.

Authors:  Wenzhuo Y Wang; Kensei Komatsu; Yuxian Huang; Jing Wu; Wenhong Zhang; Ji-Yun Lee; Masanori Miyata; Haidong Xu; Jian-Dong Li
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

10.  From microbial gene essentiality to novel antimicrobial drug targets.

Authors:  Fredrick M Mobegi; Sacha A F T van Hijum; Peter Burghout; Hester J Bootsma; Stefan P W de Vries; Christa E van der Gaast-de Jongh; Elles Simonetti; Jeroen D Langereis; Peter W M Hermans; Marien I de Jonge; Aldert Zomer
Journal:  BMC Genomics       Date:  2014-11-05       Impact factor: 3.969

View more
  2 in total

1.  Pneumococcal conjugate vaccines for preventing acute otitis media in children.

Authors:  Alexandre C Fortanier; Roderick P Venekamp; Chantal Wb Boonacker; Eelko Hak; Anne Gm Schilder; Elisabeth Am Sanders; Roger Amj Damoiseaux
Journal:  Cochrane Database Syst Rev       Date:  2019-05-28

2.  Pneumococcal conjugate vaccines for preventing acute otitis media in children.

Authors:  Joline Lh de Sévaux; Roderick P Venekamp; Vittoria Lutje; Eelko Hak; Anne Gm Schilder; Elisabeth Am Sanders; Roger Amj Damoiseaux
Journal:  Cochrane Database Syst Rev       Date:  2020-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.